Loading clinical trials...
Loading clinical trials...
Evaluation of Priming Effects by Pandemic Live Attenuated Influenza Vaccine (LAIV Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2)) on the Subsequent Response to Inactivated H5N1 Vaccine in Healthy Thai Volunteers: A Non-Randomized, Open Label Study
Conditions
Interventions
OrniFlu® inactivated vaccine
Locations
1
Thailand
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University
Bangkok, Bangkok, Thailand
Start Date
June 1, 2014
Primary Completion Date
September 1, 2014
Completion Date
September 1, 2014
Last Updated
April 9, 2015
NCT07240558
NCT02839330
NCT03318315
NCT00561184
NCT00895544
NCT01107262
Lead Sponsor
Mahidol University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions